MindMed
BioTech/Drugs - New York, NY, US
MindMed Details
MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.
MindMed Technologies
Email Providers
Outlook
CMS
WP Engine
Other
Google Apps
Email Delivery
Mailchimp Mandrill
CSS and JavaScript Libraries
VueJS